Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease.

Friedewald VE, Ganz P, Kremer JM, Mease PJ, O'Dell JR, Pearson TA, Ram CV, Ridker PM, Salmon JE, Roberts WC.

Am J Cardiol. 2010 Aug 1;106(3):442-7. doi: 10.1016/j.amjcard.2010.04.005. Review. No abstract available. Erratum in: Am J Cardiol. 2012 Mar 1;109(5):e1.

PMID:
20643261
2.
3.

Reducing the cardiovascular disease burden in rheumatoid arthritis.

Van Doornum S, Jennings GL, Wicks IP.

Med J Aust. 2006 Mar 20;184(6):287-90. Review.

PMID:
16548834
4.

Cardiovascular risk in rheumatoid arthritis.

Nurmohamed MT.

Autoimmun Rev. 2009 Jul;8(8):663-7. doi: 10.1016/j.autrev.2009.02.015. Epub 2009 Feb 12. Review.

PMID:
19393192
5.

TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.

Nasir A, Greenberg JD.

Bull NYU Hosp Jt Dis. 2007;65(3):178-81. Review.

6.

Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds.

Ravindran V, Hughes RA.

J Rheumatol. 2010 Jan;37(1):200; author reply 201-2. doi: 10.3899/jrheum.090758. No abstract available.

PMID:
20040642
7.

[Excess mortality from cardiovascular disease in patients with rheumatoid arthritis].

Lindhardsen J, Gislason GH, Ahlehoff O, Madsen OR, Hansen PR.

Ugeskr Laeger. 2011 Jan 31;173(5):343-6. Danish.

PMID:
21276397
8.

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ.

Rheumatology (Oxford). 2010 Feb;49(2):295-307. doi: 10.1093/rheumatology/kep366. Epub 2009 Nov 27. Review.

PMID:
19946022
9.

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study.

Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, Angel K, Atar D, Kvien TK.

Ann Rheum Dis. 2011 May;70(5):812-7. doi: 10.1136/ard.2010.141523. Epub 2011 Feb 2.

PMID:
21288959
10.

Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.

Chighizola C, Schioppo T, Ingegnoli F, Meroni PL.

Curr Vasc Pharmacol. 2012 Sep;10(5):639-46. Review.

PMID:
22272912
11.

Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.

Giles JT.

Best Pract Res Clin Rheumatol. 2015 Aug-Dec;29(4-5):597-613. doi: 10.1016/j.berh.2015.09.003. Epub 2015 Nov 18. Review.

PMID:
26697769
12.

Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?

Kaplan MJ.

Nat Clin Pract Rheumatol. 2005 Dec;1(2):74-5. No abstract available.

PMID:
16932633
13.
14.

Editor's choice: cardiovascular disease and rheumatoid arthritis.

Bannon M.

QJM. 2011 Jan;104(1):1-2. doi: 10.1093/qjmed/hcq246. No abstract available.

PMID:
21156664
15.

Obesity and cardiovascular risk factors in rheumatoid arthritis.

Armstrong DJ, McCausland EM, Quinn AD, Wright GD.

Rheumatology (Oxford). 2006 Jun;45(6):782; author reply 782-3. Epub 2006 Apr 21. No abstract available.

PMID:
16632480
16.

Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved?

Martín-Martínez MA, Castañeda S, González-Juanatey C, Llorca J, Díaz-Gonzalez F, González-Gay MA.

Semin Arthritis Rheum. 2015 Jun;44(6):e20-1. doi: 10.1016/j.semarthrit.2014.11.007. Epub 2014 Dec 3. No abstract available.

PMID:
25648677
17.

Cardiovascular risk assessment in rheumatoid arthritis and other inflammatory arthritides.

Meriño-Ibarra E.

Semin Arthritis Rheum. 2015 Jun;44(6):e19. doi: 10.1016/j.semarthrit.2014.11.004. Epub 2014 Nov 29. No abstract available.

PMID:
25556919
18.

Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.

Nandi P, Kingsley GH, Scott DL.

Curr Opin Rheumatol. 2008 May;20(3):251-6. doi: 10.1097/BOR.0b013e3282fb7caa. Review.

PMID:
18388514
19.

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.

Giles JT, Post W, Blumenthal RS, Bathon JM.

Nat Clin Pract Rheumatol. 2006 Jun;2(6):320-9. Review.

PMID:
16932711
20.

Supplemental Content

Support Center